<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page1_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page1_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>11</o:Revision>
  <o:TotalTime>429</o:TotalTime>
  <o:Created>2006-08-23T18:03:00Z</o:Created>
  <o:LastSaved>2006-09-01T13:36:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>617</o:Words>
  <o:Characters>3521</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>29</o:Lines>
  <o:Paragraphs>7</o:Paragraphs>
  <o:CharactersWithSpaces>4324</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	font-style:italic;}
h3
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Times New Roman";
	color:#FF9900;}
h6
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:36.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman";
	color:white;
	font-weight:normal;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1031"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:147.75pt;
 height:48pt'>
 <v:imagedata src="./Page1_files/image001.png" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=197 height=64
src="./Page1_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%" bgcolor="#003366"
 style='width:100.0%;background:#003366;border-collapse:collapse;mso-padding-alt:
 0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td valign=top style='padding:0cm 5.4pt 0cm 5.4pt'>
  <h6>Protein of the Month</h6>
  </td>
 </tr>
</table>

<p class=MsoNormal>July 2006</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;
 border-collapse:collapse;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width="33%" style='width:33.34%;border-top:solid #003366 .5pt;border-left:
  none;border-bottom:solid #003366 .5pt;border-right:none;background:#E0EFFF;
  mso-shading:windowtext;mso-pattern:horz-cross #BBDDFF;padding:0cm 5.4pt 0cm 5.4pt'>
  <h3><span style='color:#003366'>MORE ON THIS MONTH’S PROTEIN<o:p></o:p></span></h3>
  </td>
  <td width="15%" valign=top style='width:15.0%;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right'><![if !supportEmptyParas]>&nbsp;<![endif]><b><span
  style='color:#FF9900'><o:p></o:p></span></b></p>
  </td>
  <td width="33%" style='width:33.32%;border-top:solid #003366 .5pt;border-left:
  none;border-bottom:solid #003366 .5pt;border-right:none;background:#E0EFFF;
  mso-shading:windowtext;mso-pattern:horz-cross #BBDDFF;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><span
  style='color:#003366'>OTHER PROTEINS OF INTEREST<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr>
  <td width="33%" valign=top style='width:33.34%;border:none;mso-border-top-alt:
  solid #003366 .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal><a
  href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb79_1.html"
  title="Link to the structural features of APP"><span style='text-decoration:
  none;text-underline:none'><!--[if gte vml 1]><v:shape id="_x0000_i1026"
   type="#_x0000_t75" style='width:109.5pt;height:28.5pt'>
   <v:imagedata src="./Page1_files/image003.png" o:title="PDB_original"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=146 height=38
  src="./Page1_files/image004.gif" v:shapes="_x0000_i1026"><![endif]></span></a></p>
  <p class=MsoNormal><a
  href="http://www.rcsb.org/pdb/static.do?p=education_discussion/molecule_of_the_month/pdb79_1.html"
  title="Link to the structural features of APP">Molecule of the Month: APP</a></p>
  <p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
  <td width="15%" valign=top style='width:15.0%;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
  <td width="33%" valign=top style='width:33.32%;border:none;mso-border-top-alt:
  solid #003366 .5pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=right style='text-align:right'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal align=right style='text-align:right'><a
  href="http://www.expasy.org/spotlight/"
  title="ExPASy Protein Spotlight Article"><span style='text-decoration:none;
  text-underline:none'><!--[if gte vml 1]><v:shape id="_x0000_i1027" type="#_x0000_t75"
   style='width:168pt;height:28.5pt'>
   <v:imagedata src="./Page1_files/image005.jpg" o:title="Expasy_protein_spotlight"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=224 height=38
  src="./Page1_files/image006.jpg" v:shapes="_x0000_i1027"><![endif]></span></a></p>
  <p class=MsoNormal align=right style='text-align:right'><a
  href="http://www.expasy.org/spotlight/" title="ExPASy Protein Spotlight">ExPASy
  Protein Spotlight</a></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'><span style='font-size:36.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Amyloid-</span><span style='font-size:
36.0pt;mso-bidi-font-size:16.0pt;font-family:Symbol;color:navy'>b</span><span
style='font-size:36.0pt;mso-bidi-font-size:16.0pt;color:navy'> Precursor
Protein<o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-size:14.0pt;
mso-bidi-font-size:16.0pt;font-family:"Times New Roman";font-weight:normal'>By <a
href="mailto:jennifer@ebi.ac.uk?subject=Protein%20of%20the%20Month"
title="Contact the author">Jennifer McDowall</a><o:p></o:p></span></h1>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Alzheimer’s
disease (AD) is the most common form of dementia in the elderly.<span
style="mso-spacerun: yes">  </span>A progressive neurodegenerative disease, AD
is characterised by memory loss, confusion, impaired judgement, personality
changes, loss of language skills, and eventually by death.<span
style="mso-spacerun: yes">  </span>In AD patients, brain cells that process,
store and retrieve information degenerate and die, resulting in a profound loss
of basal forebrain cholinergic neurons that innervate the hippocampus and
neocortex.<span style="mso-spacerun: yes">  </span>Amyloid<span
style="mso-spacerun: yes">  </span>(or senile) plaques and neurofibrillary
tangles are hallmarks of the disease.<span style="mso-spacerun: yes"> 
</span>Although the direct cause of AD is still unclear, a prime suspect is
amyloid-<span style='font-family:Symbol'>b</span> peptide (A<span
style='font-family:Symbol'>b</span>), which accumulates in brain tissue in AD
patients, forming extracellular deposits of amyloid plaques composed primarily
of aggregated amyloid-<span style='font-family:Symbol'>b</span> peptide.<span
style="mso-spacerun: yes">  </span>Plaques similar to those found in AD
patients have also been found in some variants of Lewy Body Dementia, and
coating cerebral blood vessels in Cerebral Amyloid Angiopathy.<span
style="mso-spacerun: yes">  </span>Amyloid-<span style='font-family:Symbol'>b</span>
is a protein fragment derived from the breakdown of amyloid-<span
style='font-family:Symbol'>b</span> precursor protein (APP).<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Amyloid-</span><span
style='font-family:Symbol;color:navy;font-style:normal'>b</span><span
style='color:navy;font-style:normal'> Precursor Protein, Still an Enigma.<o:p></o:p></span></h2>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>APP is a
conserved glycoprotein embedded in the membrane surrounding neuronal cells,
protruding both inside and outside the cell.<span style="mso-spacerun: yes"> 
</span>APP consists of a large N-terminal extracellular domain, a short
hydrophobic transmembrane domain, and a short intracellular C-terminal domain.<span
style="mso-spacerun: yes">  </span>Mutations in APP, or in proteins that
process APP, have been linked with familial Alzheimer’s disease (FAD), causing
early-onset of symptoms, possibly by affecting APP processing that in turn
alters A<span style='font-family:Symbol'>b</span> production and plaque
formation.<span style="mso-spacerun: yes">  </span>Individuals with Down’s
Syndrome carry an extra copy of chromosome 21, which contains the APP gene, and
almost invariably develop amyloid plaques and Alzheimer’s symptoms, possibly
through the over-production of APP, and therefore of A<span style='font-family:
Symbol'>b</span>. </p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>However,
APP has a role to play besides A<span style='font-family:Symbol'>b</span>
production, appearing to have a number of important developmental and postnatal
neurological functions.<span style="mso-spacerun: yes">   </span>These
functions may be elicited through the N-terminal extracellular domain or the
C-terminal cytoplasmic domain, both regions appearing to have important roles
in neurogenesis and neuronal regeneration.<span style="mso-spacerun: yes"> 
</span></p>

<p class=MsoBodyText style='text-indent:36.0pt'>The N-terminal extracellular
domain is cysteine-rich and similar in structure to growth factors such as
hepatocyte growth factor.<span style="mso-spacerun: yes">  </span>It also has
both heparin and copper-binding sites.<span style="mso-spacerun: yes"> 
</span>This domain may function as a cell surface receptor on the surface of
neurons, contributing to neurite growth, neuronal adhesion and axonogenesis, as
well as cell mobility.<span style="mso-spacerun: yes">  </span>APP acts as a
kinesin I membrane receptor to mediate the axonal transport of <span
style='font-family:Symbol'>b</span>-secretase and presenilin 1.<span
style="mso-spacerun: yes">  </span>The N-terminal domain can regulate neurite
outgrowth through its binding to heparin and collagen I and IV, which are
components of the extracellular matrix.<span style="mso-spacerun: yes"> 
</span>APP is also coupled to apoptosis-inducing pathways, and is involved in
copper homeostasis/oxidative stress through copper ion reduction, where
copper-metallated APP induces neuronal death.</p>

<p class=MsoBodyText style='text-indent:36.0pt'>The C-terminal intracellular
domain appears to be involved in transcription regulation through
protein-protein interactions.<span style="mso-spacerun: yes">  </span>APP can
promote transcription activation through binding to APBB1/Tip60, and may bind
to the adaptor protein FE65 to transactivate a wide variety of different
promoters.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText><span style='font-size:20.0pt;mso-bidi-font-size:12.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<h1 align=center style='text-align:center'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page2.htm" title="Page 2">Amyloid Plaque Formation</a></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
